Olr402 inhibitors represent a specialized class of chemical compounds that interact with the Olr402 protein, a member of the olfactory receptor (OR) family. Olfactory receptors are G protein-coupled receptors (GPCRs) located primarily in the sensory neurons of the olfactory epithelium, where they play a crucial role in the detection and transduction of odorant signals. The Olr402 protein is one of many ORs found in various species, and it is implicated in the recognition of specific chemical structures that contribute to odor perception. The inhibition of Olr402 involves the binding of these inhibitors to the receptor, preventing the normal ligand-receptor interaction that would typically result in signal transduction across the olfactory neural pathway. By studying these inhibitors, researchers can gain insights into the molecular mechanisms underlying odor recognition, receptor specificity, and the broader functions of the olfactory system.
The chemical nature of Olr402 inhibitors can vary significantly, depending on the molecular structure required to interact effectively with the receptor's active site. These inhibitors are typically designed or identified through methods such as high-throughput screening, molecular docking, and structure-activity relationship (SAR) analysis. The molecular structure of these inhibitors often features specific functional groups or motifs that complement the binding pocket of the Olr402 receptor, ensuring a high affinity and selectivity for this particular OR. Through detailed examination of the structural properties and binding dynamics of Olr402 inhibitors, researchers can map out the conformational changes and signal transduction mechanisms involved in olfactory perception. This information is vital for advancing the understanding of olfactory receptor function, as well as for exploring the evolutionary diversity and adaptation of the olfactory system across different species.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(RS)-Atenolol | 29122-68-7 | sc-204895 sc-204895A | 1 g 10 g | $77.00 $408.00 | 1 | |
Beta-1 adrenergic receptor antagonist, can modulate GPCR signaling pathways, potentially impacting Olr402. | ||||||
Eprosartan | 133040-01-4 | sc-207631 | 10 mg | $166.00 | 1 | |
Angiotensin II receptor blocker, could indirectly influence GPCR signaling, potentially affecting Olr402. | ||||||
Fenofibrate | 49562-28-9 | sc-204751 | 5 g | $40.00 | 9 | |
PPAR alpha agonist, might affect GPCR signaling indirectly through lipid metabolism modulation, impacting Olr402. | ||||||
Irbesartan | 138402-11-6 | sc-218603 sc-218603A | 10 mg 50 mg | $104.00 $297.00 | 3 | |
Angiotensin II receptor antagonist, can alter GPCR signaling indirectly, potentially impacting Olr402. | ||||||
Labetalol | 36894-69-6 | sc-484723 | 50 mg | $176.00 | ||
Alpha and beta adrenergic blocker, may modulate GPCR signaling, potentially affecting Olr402. | ||||||
(R)-Cetirizine Dihydrochloride | 130018-77-8 | sc-212682 | 10 mg | $300.00 | ||
Histamine H1 receptor antagonist, could indirectly affect GPCR signaling, impacting Olr402. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $118.00 $320.00 $622.00 $928.00 $1234.00 | 38 | |
PPAR gamma agonist, can affect GPCR signaling indirectly via glucose metabolism pathways, impacting Olr402. | ||||||
Telmisartan | 144701-48-4 | sc-204907 sc-204907A | 50 mg 100 mg | $71.00 $92.00 | 8 | |
Angiotensin II receptor blocker, could alter GPCR signaling pathways indirectly, potentially impacting Olr402. | ||||||
Valsartan | 137862-53-4 | sc-220362 sc-220362A sc-220362B | 10 mg 100 mg 1 g | $39.00 $90.00 $120.00 | 4 | |
Angiotensin II receptor antagonist, might indirectly affect GPCR signaling, potentially impacting Olr402. | ||||||